Pear Therapeutics, Inc.
PEAR · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $48 | $170 | $111 | $27 |
| Short-Term Investments | $11 | $5 | $14 | $77 |
| Receivables | $7 | $2 | $0 | $1 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $7 | $9 | $1 | $2 |
| Total Curr. Assets | $73 | $185 | $126 | $107 |
| Property Plant & Equip (Net) | $15 | $6 | $4 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $7 | $6 | $2 | $2 |
| Total NC Assets | $22 | $12 | $6 | $3 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $95 | $197 | $132 | $110 |
| Liabilities | – | – | – | – |
| Payables | $3 | $2 | $5 | $3 |
| Short-Term Debt | $29 | $27 | $26 | $4 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $4 |
| Other Curr. Liab. | $16 | $18 | $10 | $6 |
| Total Curr. Liab. | $49 | $47 | $41 | $17 |
| LT Debt | $8 | $0 | $0 | $11 |
| Deferred Rev, NC | $0 | $0 | $0 | $3 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $145 |
| Other NC Liab. | $7 | $60 | $274 | $1 |
| Total NC Liab. | $15 | $60 | $274 | $159 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $65 | $107 | $315 | $176 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$323 | -$248 | -$183 | -$70 |
| AOCI | -$0 | -$0 | $0 | $0 |
| Other Equity | $354 | $338 | $1 | $4 |
| Total Equity | $31 | $90 | -$182 | -$66 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $95 | $197 | $132 | $110 |
| Net Debt | -$11 | -$143 | -$85 | -$12 |